Skip to main content

Table 4 Baseline biological characteristics of children who died

From: Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

Pt# Sex Age (Yrs) WHO Stage WAZ CD4% ARV Regimen ARV time to death (weeks) ALB(g/L) ALT(IU/L) HGB(g/dl) Suspected cause of death
1 M 0.3 4 - 37.6% d4T/3TC/Kal 09 25.0 14.0 9.9 Chronic gastroenteritis
2 F 7.5 4 -9.52 7.9% AZT/3TC/EFV 20 18.0 33.0 10.7 TB Miliary
3 F 9.8 4 -4.34 0.8% d4T/3TC/EFV 14 30.0 12.0 7.9 TB Adenopathy
4 M 3.0 4 -4.81 - AZT/3TC/Kal 10 - - 9.1 TB Lymph
5 F 7.1 3 -5.94 8.0% d4T/3TC/EFV 06 32.0 24.0 11.7 Chronic gastroenteritis
6 F 0.8 3 -7.50 6.0% d4T/3TC/Kal 01 26.0 116.0 7.0 Chronic gastroenteritis
7 F 1.5 4 -5.42 27.0% d4T/3TC/RTV 05 28.0 53.0 10.2 TB Abdomen
8 F 13.4 3 -9.51 2.1% d4T/3TC/EFV 02 - - 10.1 Chronic gastroenteritis
9 M 0.5 4 -5.24 4.0% d4T/3TC/Kal 05 25.0 45.0 11.7 Chronic gastroenteritis
10 M 6.3 3 - 1.1% AZT/3TC/EFV 05 39.0 16.0 9.3 Chronic gastroenteritis
11 M 12.2 3 -6.95 1.0% d4T/3TC/EFV 06 - - 5.6 Suspected PCP
12 F 1.1 3 -0.87 1.0% d4T/3TC/Kal 01 19.0 8.0 4.1 Sepsis syndrome
13 M 5.2 3 -6.71 0.5% d4T/3TC/EFV 08 28.0 8.3 7.0 Respiratory tract infection
  1. d4T, stavudine; 3TC, lamivdine; AZT, zidovudine; ddI, didanosine; EFV, efavirenz; RTV, Ritonavir; Kal, Kaletra™